PATEL SANJIV (President and CEO) sold 19.6% of their position (215.51K shares) of RELAY THERAPEUTICS, INC. on the open market
Open‑market sale worth $818.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/13/2025ACC: 0000950170-25-020272
DirectorOfficer· President and CEO
Since Jul 2020
+116.96K
Net shares
Net buyer
$818.4K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
332.46K acquired · 215.51K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−140.18K
Price / share
$3.85
Trade value
$539.70K
% of position
18.3%
2/11/2025
766.13K→625.95K
Common Stock
Direct
Shares
+332.46K
Price / share
—
Trade value
—
% of position
53.1%
2/11/2025
625.95K→958.41K
Common Stock
Direct
Shares
−75.32K
Price / share
$3.70
Trade value
$278.70K
% of position
7.9%
2/13/2025
958.41K→883.09K
Total
Net shares
+116.96K
Net value
-$818.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2025 | S · Sale | −140.18K | $3.85 | $539.70K | 18.3% | 766.13K | 625.95K |
| Common Stock Direct | 2/11/2025 | A · Award | +332.46K | — | — | 53.1% | 625.95K | 958.41K |
| Common Stock Direct | 2/13/2025 | S · Sale | −75.32K | $3.70 | $278.70K | 7.9% | 958.41K | 883.09K |
| Total | +116.96K | -$818.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned199.55K
Common Stock
IndirectShares owned687.36K
Total
886.90K indirect886.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 199.55K | Indirect |
| Common Stock | 687.36K | Indirect |
| Total | 886.90K | 886.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported